AMLN and ARNA
Dew, it appears you have been spot-on with your LAR concerns, and I thank you for saving me a bit of cash.
Many AMLN longs are also extremely bullish on Pramlintide (Symlin) for weight loss. I can't seem to get past the idea that a needle would scare away potential users. ARNA has a drug in clinical trials, APD-356, that seemed to show very similar efficacy to Pramlintide, but is an oral.
If it's not a bother, I'd like your opinion Dew, or anyone's for that matter, on AMLN's Pramlintide for weight loss.
I wish that I had more to offer this board than simply asking questions, but greatly appreciate all that I have learned from Dew and the countless other knowledgeable posters.
Best regards,
Geoff
Market Data 
Markets 
AI
